Streetbeat News

Products Services

ESLA

Estrella Immunopharma has appointed Hong Zhang as Chairperson and Board Member, expanding its board from five to six directors. This follows the dosing of the first patient in its Phase I/II clinical trial for EB103 T-Cell Therapy. CEO Dr. Cheng Liu will continue as a director.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 4:01 pm

TSLA

Truist analyst William Stein tested Tesla's FSD V12.5.1.1 in a Model 3 and found it still has significant issues, including illegal maneuvers. Stein maintained a Hold rating on Tesla with a $215 price target, emphasizing the importance of Tesla's AI projects to its stock value.

Portfolio Pulse from Chris Katje

August 14, 2024 | 3:55 pm

AAPL

Apple announced that starting with iOS 18.1, developers will be able to offer NFC contactless transactions using the Secure Element from within their own apps on iPhone. This new feature will support various use cases such as in-store payments, car keys, transit, corporate badges, and more. Developers will need to enter into a commercial agreement with Apple and meet certain security and regulatory standards to access the NFC and SE APIs.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 3:37 pm

KARS

KGRN

NIO

NIO Inc. (NYSE:NIO) shares are trading lower, down 1.67% to $3.825. The stock has lost over 69% in the past year. Investors can gain exposure via KraneShares MSCI China Clean Technology Index ETF (NYSE:KGRN) and KraneShares Electric Vehicles and Future Mobility Index ETF (NYSE:KARS). An Onvo executive released an interior image of the L60, NIO’s sub-brand debut model, as it approaches mass production.

Portfolio Pulse from Nabaparna Bhattacharya

August 14, 2024 | 3:35 pm

DKNG

FLUT

DraftKings (NASDAQ:DKNG) faced backlash and a drop in shares after announcing a winning bet surcharge in high-tax states, which it later reversed following Flutter Entertainment's (NYSE:FLUT) decision not to implement a similar charge. Analysts have raised their price targets for Flutter, citing strong Q2 performance and growth potential.

Portfolio Pulse from Chris Katje

August 14, 2024 | 3:30 pm

DOGG

IBM

TDVI

IBM shares are trading higher following the inclusion of two IBM-developed algorithms in the first post-quantum cryptography standards by NIST. IBM is also partnering with WWF to develop AI solutions for monitoring endangered species and has launched generative AI enhancements for its security services. IBM stock has gained around 35% in the last 12 months.

Portfolio Pulse from Lekha Gupta

August 14, 2024 | 3:30 pm

GOOG

PTON

Peloton Interactive Inc (NASDAQ:PTON) shares are experiencing increased attention due to a new content distribution deal with Alphabet Inc's (NASDAQ:GOOG) Fitbit. The partnership will offer Peloton classes to Fitbit Premium users starting in early September. Despite an initial premarket rise, Peloton shares fell by 3.64% by Wednesday afternoon.

Portfolio Pulse from Adam Eckert

August 14, 2024 | 3:23 pm

IBIT

The top four ETF launches in 2024 are all spot Bitcoin ETFs, with BlackRock's iShares Bitcoin ETF (NASDAQ:IBIT) leading the pack with $20.5 billion in assets under management. Despite Schwab being a major ETF issuer, it has yet to launch a spot Bitcoin ETF. Institutional adoption of Bitcoin ETFs is expected to increase, with Morgan Stanley allowing advisors to pitch Bitcoin ETFs to high-risk clients.

Portfolio Pulse from Khyathi Dalal

August 14, 2024 | 3:18 pm

LLY

Eli Lilly & Co. has issued cease-and-desist letters to various healthcare providers, demanding they stop selling copycat versions of its weight-loss drugs, Mounjaro and Zepbound. Despite an improving supply, a shortage of these drugs persists in the U.S.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 3:09 pm

AZN

AstraZeneca is reconsidering its $578.4 million investment in a new vaccine-manufacturing site in the UK due to a reduction in government funding. The UK Treasury has cut its support from 65 million pounds to around 40 million pounds, leading AstraZeneca to consider relocating the project to France. This decision could impact the company's vaccine manufacturing expansion plans.

Portfolio Pulse from Vandana Singh

August 14, 2024 | 3:04 pm